Find Palonosetron manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 135729-62-3, Palonosetron hcl, Aloxi, Onicit, Palonosetron (hydrochloride), Rs-25259-197
Molecular Formula
C19H25ClN2O
Molecular Weight
332.9  g/mol
InChI Key
OLDRWYVIKMSFFB-SSPJITILSA-N
FDA UNII
23310D4I19

Palonosetron
Isoquinoline and quinuclidine derivative that acts as a 5-HT3 RECEPTOR antagonist. It is used in the prevention of nausea and vomiting induced by cytotoxic chemotherapy, and for the prevention of post-operative nausea and vomiting.
1 2D Structure

Palonosetron

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one;hydrochloride
2.1.2 InChI
InChI=1S/C19H24N2O.ClH/c22-19-16-6-2-4-14-3-1-5-15(18(14)16)11-21(19)17-12-20-9-7-13(17)8-10-20;/h2,4,6,13,15,17H,1,3,5,7-12H2;1H/t15-,17-;/m1./s1
2.1.3 InChI Key
OLDRWYVIKMSFFB-SSPJITILSA-N
2.1.4 Canonical SMILES
C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5.Cl
2.1.5 Isomeric SMILES
C1C[C@@H]2CN(C(=O)C3=CC=CC(=C23)C1)[C@@H]4CN5CCC4CC5.Cl
2.2 Other Identifiers
2.2.1 UNII
23310D4I19
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1h-benz(de)isoquinolin-1-one

2. 2-qhbiqo

3. Aloxi

4. Palonosetron

5. Palonosetron, (3r)-

6. Palonosetron, (r-(r*,r*))-isomer

7. Palonosetron, (r-(r*,s*))-isomer

8. Palonosetron, (s-(r*,s*))-isomer

9. Rs 25233 197

10. Rs 25233 198

11. Rs 25233-197

12. Rs 25233-198

13. Rs 25233197

14. Rs 25233198

15. Rs 25259

16. Rs 25259 197

17. Rs 25259 198

18. Rs 25259-197

19. Rs 25259-198

20. Rs 25259197

21. Rs 25259198

22. Rs-25233-197

23. Rs-25233-198

24. Rs-25259

25. Rs-25259-197

26. Rs-25259-198

27. Rs25233197

28. Rs25233198

29. Rs25259

30. Rs25259197

31. Rs25259198

2.3.2 Depositor-Supplied Synonyms

1. 135729-62-3

2. Palonosetron Hcl

3. Aloxi

4. Onicit

5. Palonosetron (hydrochloride)

6. Rs-25259-197

7. (s,s)-palonosetron Hydrochloride

8. Palonocetron Hydrochloride

9. Palonosetron (as Hydrochloride)

10. Chebi:85157

11. Rs 25259-197

12. (3as)-2-(3s)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-1h-benz[de]isoquinolin-1-one Monohydrochloride

13. (3as)-2-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3h-benzo[de]isoquinolin-1-one;hydrochloride

14. 1h-benz[de]isoquinolin-1-one, 2-[(3s)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-, Hydrochloride (1:1), (3as)-

15. 23310d4i19

16. Aloxi (tn)

17. Dsstox_cid_26610

18. Dsstox_rid_81765

19. Dsstox_gsid_46610

20. (3as)-2,3,3a,4,5,6-hexahydro-2-((3s)-3-quinuclidinyl)-1h-benz(de)isoquinolin-1-one Monohydrochloride

21. (s)-2-((s)-quinuclidin-3-yl)-2,3,3a,4,5,6-hexahydro-1h-benzo[de]isoquinolin-1-one Hydrochloride

22. (r,s)-palonosetron Hcl

23. (s,r)-palonosetron Hcl

24. Cas-135729-62-3

25. Palonosetron Related Compound C

26. Palonosetron Related Compound D

27. Onicita

28. Paloxi

29. Palonosetron Hydrochloride [usan]

30. Unii-23310d4i19

31. Palonosetron Hydrochloride [usan:jan]

32. Palonosetronhydrochloride

33. Ncgc00166415-01

34. Chembl1720

35. Mls001424202

36. Schembl182478

37. Rs 25259 197

38. Dtxsid8046610

39. (3as)-palonosetron Hydrochloride

40. Palonosetron Hydrochloride- Bio-x

41. Palonosetron Hydrochloride (aloxi)

42. Ex-a4360

43. Hy-a0021

44. Tox21_112421

45. Mfcd00939524

46. Nsc743769

47. S3050

48. Palonosetron Hydrochloride (jan/usp)

49. Akos015895112

50. Akos026751493

51. Tox21_112421_1

52. Ac-1293

53. Ccg-101081

54. Ccg-221268

55. Cs-0621

56. Nc00331

57. Palonosetron Hydrochloride [mi]

58. Palonosetron Hydrochloride [jan]

59. Ncgc00166415-03

60. (3as)-2-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3h-benzo[de]isoquinolin-1-one Hydrochloride

61. As-75066

62. Bp164227

63. Palonosetron Hydrochloride [mart.]

64. Rs 25259

65. Smr000469233

66. Palonosetron Hydrochloride [usp-rs]

67. Palonosetron Hydrochloride [who-dd]

68. Palonosetron Hydrochloride, >=98% (hplc)

69. P-225

70. P2051

71. Palonosetron Hydrochloride [ema Epar]

72. D05343

73. Palonosetron Hydrochloride [orange Book]

74. 729p623

75. Akynzeo Component Palonosetron Hydrochloride

76. Palonosetron Hydrochloride [usp Monograph]

77. 7-amino-3-(hydroxymethyl)-3-cephem-4-carboxylicacid

78. Palonosetron Hydrochloride Component Of Akynzeo

79. Q27158366

80. (s,r)-palonosetron Hydrochloride Contains Up To ~35% (r,r)-isomer

81. 1h-benz[de]isoquinolin-1-one,3,3a,4,5,6-hexahydro-, (3as)- Hydrochloride

82. 1h-benz[de]isoquinolin-1-one,3,3a,4,5,6-hexahydro-, [s-(r*,r*)]-, Hydrochloride

83. Palonosetron Hydrochloride, United States Pharmacopeia (usp) Reference Standard

84. (3as)-2-[(3s)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1h-benz[de]isoquinolin-1-one Hydrochloride

85. (3as)-2-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-2,3,3a,4,5,6-hexahydro-1h-benzo[de]isoquinolin-1-one--hydrogen Chloride (1/1)

86. (3as)-2-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3h-benzo[de]isoquinolin-1-one;hydrochloride.

87. (3as)-2-[(s)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1-oxo-1h-benz[de]isoquinoline Hydrochloride

88. (3s)-3-[(3as)-1-oxo-3a,4,5,6-tetrahydro-1h-benzo[de]isoquinolin-2(3h)-yl]-1-azabicyclo[2.2.2]octan-1-ium Chloride

89. (5s)-3-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-3-azatricyclo[7.3.1.0?,(1)(3)]trideca-1(13),9,11-trien-2-one Hydrochloride

90. 1h-benz(de)isoquinolin-1-one, 2-(3s)-1-azabicyclo(2.2.2)oct-3-yl-2,3,3a,4,5,6-hexahydro-, Monohydrochloride, (3as)-

2.4 Create Date
2006-07-28
3 Chemical and Physical Properties
Molecular Weight 332.9 g/mol
Molecular Formula C19H25ClN2O
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count1
Exact Mass332.1655411 g/mol
Monoisotopic Mass332.1655411 g/mol
Topological Polar Surface Area23.6 Ų
Heavy Atom Count23
Formal Charge0
Complexity456
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NamePalonosetron hydrochloride
Drug LabelALOXI (palonosetron hydrochloride) is an antiemetic and antinauseant agent. It is a serotonin-3 (5-HT3) receptor antagonist with a strong binding affinity for this receptor. Chemically, palonosetron hydrochloride is: (3aS)-2-[(S)-1-Azabicyclo [2.2.2]...
Active IngredientPalonosetron hydrochloride
Dosage FormInjectable
Routeinjection
Strength0.25mg/0.25ml; 0.25mg/5ml; 0.05mg/ml; 0.075mg/1.5ml
Market StatusTentative Approval
CompanyTeva Pharms; Dr Reddys Labs

2 of 2  
Drug NamePalonosetron hydrochloride
Drug LabelALOXI (palonosetron hydrochloride) is an antiemetic and antinauseant agent. It is a serotonin-3 (5-HT3) receptor antagonist with a strong binding affinity for this receptor. Chemically, palonosetron hydrochloride is: (3aS)-2-[(S)-1-Azabicyclo [2.2.2]...
Active IngredientPalonosetron hydrochloride
Dosage FormInjectable
Routeinjection
Strength0.25mg/0.25ml; 0.25mg/5ml; 0.05mg/ml; 0.075mg/1.5ml
Market StatusTentative Approval
CompanyTeva Pharms; Dr Reddys Labs

4.2 Drug Indication

Aloxi is indicated in adults for:

- the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy,

- the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

Aloxi is indicated in paediatric patients 1 month of age and older for:

- the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Antiemetics

Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)


Serotonin 5-HT3 Receptor Antagonists

Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS. (See all compounds classified as Serotonin 5-HT3 Receptor Antagonists.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Serotonin-3 Receptor Antagonist [EPC]; Serotonin 3 Receptor Antagonists [MoA]
5.3 ATC Code

A04AA05


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Palonosetron Hydrochloride IH

Date of Issue : 2025-05-28

Valid Till : 2028-06-25

Written Confirmation Number : WC-0035

Address of the Firm : Chemical Technical Operations, Unit -Ill, Plot No. 116,Sri Venkateswara Co-opera...

Dr Reddy Company Banner

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Palonosetron Hydrochloride IH

Date of Issue : 2022-07-06

Valid Till : 2025-06-25

Written Confirmation Number : WC-0057n

Address of the Firm : Plot No. 3109, GIDC, Industrial Estate Ankleshwar, Distt- Bharuch - 393002, Guja...

blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Palonosetron Hydrochloride IH

Date of Issue : 2025-08-08

Valid Till : 2028-06-10

Written Confirmation Number : WC-0017

Address of the Firm : Unit-II, SurveyNo.:10&13,Gaddapotharam (Village), IDA-Kazipally, Jinnaram (Manda...

blank

04

Cipla

India
PEGS Boston Summit
Not Confirmed
arrow

Cipla

India
arrow
PEGS Boston Summit
Not Confirmed

Palonosetron Hydrochloride IH

Date of Issue : 2025-08-29

Valid Till : 2028-08-28

Written Confirmation Number : WC-0142

Address of the Firm : A-33, A-37/2/2 & A-2, M.I.D.C., Patalganga -410220, Taluka: Khalapur, District: ...

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Palonosetron Hydrochloride IH

Date of Issue : 2025-09-26

Valid Till : 2028-07-02

Written Confirmation Number : WC-0226

Address of the Firm : D-24 & D-24/1, M.I.D.C., Kurkumbh, Taluka: Daund, District. Pune -413802, Mahara...

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Palonosetron Hydrochloride IH/USP

Date of Issue : 2025-09-19

Valid Till : 2028-05-05

Written Confirmation Number : WC-0349

Address of the Firm : Unit-II, Sy. Nos. 50, 53, 53/A, 54 & 54/A,Kardanur (Village), Patancheru (Mandal...

blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Palonosetron HCL USP

Date of Issue : 2025-08-01

Valid Till : 2028-07-02

Written Confirmation Number : WC-0231

Address of the Firm : D. No 6-233, Sarpavaram, Kakinada -533005, Kakinada District, Andhra Pradesh, In...

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Palonosetron HCI IH/USP

Date of Issue : 2025-07-14

Valid Till : 2028-02-06

Written Confirmation Number : WC-0012

Address of the Firm : B-1/8,MIDC, Lote Parshuram, Tal., Dist. Ratnagiri, Khed - 415722, Taluka: Khed, ...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCentury has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.

Flag India
Digital Content Digital Content

Palonosetron

About the Company : Century Pharmaceuticals, established in 1982, has 40 years of experience manufacturing APIs for major pharma companies in India and abroad. Its products are made in compliance with...

Century Pharmaceuticals, established in 1982, has 40 years of experience manufacturing APIs for major pharma companies in India and abroad. Its products are made in compliance with cGMP, 21 CFR, and ICH guidelines, and it also produces intermediates and develops new APIs as per client requirements. The company conducts biotechnological research on human therapeutic proteins, including treatments for asthma, mastocytosis, and basophilic leukemia, and supplies research-grade biotech and animal health products. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Century Company Banner

02

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Palonosetron

About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...

LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product CDMO, offering formulation, analytical method development and testing, regulatory support, and commercial manufacturing. Supported by a network of over 220 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
LGM Pharma CB

03

Seqens

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Flag France
Digital Content Digital Content

Palonosetron

About the Company : Founded in 2003, Seqens has evolved into a global leader in pharmaceutical solutions and specialty ingredients. The company supports customers in the development, scale-up, and man...

Founded in 2003, Seqens has evolved into a global leader in pharmaceutical solutions and specialty ingredients. The company supports customers in the development, scale-up, and manufacturing of drug substances from pre-clinical to commercial stages. Seqens offers a broad portfolio of APIs and proprietary products, along with custom solutions for healthcare, electronics, and cosmetics. With 15 industrial plants and 5 R&D centers worldwide, Seqens produces complex molecules across small- and large-scale requirements. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Seqens Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Palonosetron

About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...

Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale
Dr Reddy Company Banner

05

HRV Pharma

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Palonosetron

About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...

HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing, manufacturing, and supply services to support partners entering new markets worldwide. HRV Pharma works closely with major pharma and food additive companies and represents over 30 Indian drugmakers, primarily serving Europe, the US, and the Middle East. Headquartered in India, it operates offices in the US, Switzerland, Dubai, Lithuania, and Turkey. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
HRV Global Life Sciences

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALONOSETRON HCL

About the Company : Chongqing Huapont Pharmaceutical Co., Ltd. was established in 1994 and is now located in Liangjiang New District, Chongqing. It is a national high-tech enterprise, a national innov...

Chongqing Huapont Pharmaceutical Co., Ltd. was established in 1994 and is now located in Liangjiang New District, Chongqing. It is a national high-tech enterprise, a national innovative enterprise, and a national demonstration enterprise for a new model of intelligent manufacturing. It has a national enterprise technology center and multiple municipal R&D platforms, two formulation factories, and two API factories. In addition, the company is also widely involved in the fields of respiratory, cardiovascular and cerebrovascular, blood, tumor, and systemic hormones, and has accumulated a large number of blockbuster drugs.
blank

07

Cipla

India
PEGS Boston Summit
Not Confirmed
arrow

Cipla

India
arrow
PEGS Boston Summit
Not Confirmed

Palonosetron

About the Company : Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission i...

Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission is to be a leading global healthcare company which uses technology and innovation to meet everyday needs of all patients. Since inception in 1935, caring has been at the core of everything we do at Cipla. For patients, caring is a promise that we will do whatever it takes to ensure they have continued access to the highest quality medicines at affordable prices; whether a disease affects millions or just a few hundreds.
blank

08

Farmhispania

Spain
PEGS Boston Summit
Not Confirmed
arrow

Farmhispania

Spain
arrow
PEGS Boston Summit
Not Confirmed

Palonosetron

About the Company : Farmhispania Group comprises two companies in Spain: Farmhispania in Barcelona and Rolabo in Zaragoza. Since its inception, the group has consistently invested in advanced equipmen...

Farmhispania Group comprises two companies in Spain: Farmhispania in Barcelona and Rolabo in Zaragoza. Since its inception, the group has consistently invested in advanced equipment, new technologies, and enhanced capabilities. Significant investments include the implementation of hydrogenation technologies in 2007, HPAPI handling capabilities in 2010, highly potent fermentation capabilities in 2014, and the expansion of large-scale preparative chromatography in 2015. Additionally, Farmhispania Group actively collaborates on numerous projects with various universities and research organizations both nationally and internationally.
blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Palonosetron

About the Company : At Freemen Nutra, the focus is on empowering both individuals and customers to achieve greater success. The company specializes in providing high-quality nutritional ingredients an...

At Freemen Nutra, the focus is on empowering both individuals and customers to achieve greater success. The company specializes in providing high-quality nutritional ingredients and solutions for various industries, including food and beverage, dietary supplements, personal care, and animal nutrition. Freemen Nutra is dedicated to assisting clients in these markets to bring their innovative ideas to fruition. The company stands out as a leading distributor of raw ingredients, offering ethically sourced and exceptional ingredients that contribute to improved product performance, taste, and nutritional benefits for brands.
blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Palonosetron

About the Company : Located in Jinan, Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. It focuses on developing, manufacturing and marketing of generic drugs and active pha...

Located in Jinan, Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. It focuses on developing, manufacturing and marketing of generic drugs and active pharmaceutical ingredients in the therapeutic areas of Oncology, Cerebrovascular & Cardiovascular, Infections, Psychological and Neurological System, Respiratory System, Ophthalmological Diseases, etc. Always committing itself to meet the needs of the patients and the society. Qilu pharmaceutical provides high-quality products by adopting advanced technology. Qilu has 8000 employees , 5,000 of them have junior college or above educational backgrounp.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - CAPSULE;ORAL - 300MG;EQ 0.5MG BASE

USFDA APPLICATION NUMBER - 205718

read-more

DOSAGE - SOLUTION;INTRAVENOUS - EQ 0.25MG BAS...DOSAGE - SOLUTION;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)

USFDA APPLICATION NUMBER - 208109

read-more

DOSAGE - POWDER;INTRAVENOUS - EQ 235MG BASE/V...DOSAGE - POWDER;INTRAVENOUS - EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL

USFDA APPLICATION NUMBER - 210493

read-more

DOSAGE - SOLUTION;INTRAVENOUS - EQ 235MG BASE...DOSAGE - SOLUTION;INTRAVENOUS - EQ 235MG BASE/20ML (EQ 11.75MG BASE/ML);EQ 0.25MG BASE/20ML (EQ 0.0125MG BASE/ML)

USFDA APPLICATION NUMBER - 210493

read-more

DOSAGE - INJECTABLE;INTRAVENOUS - EQ 0.075MG ...DOSAGE - INJECTABLE;INTRAVENOUS - EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21372

read-more

DOSAGE - INJECTABLE;INTRAVENOUS - EQ 0.25MG B...DOSAGE - INJECTABLE;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21372

read-more

DOSAGE - CAPSULE;ORAL - EQ 0.5MG BASE **Feder...DOSAGE - CAPSULE;ORAL - EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 22233

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Lubricants & Glidants

read-more
read-more

Parenteral

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Granulation

read-more
read-more

Empty Capsules

read-more
read-more

Coating Systems & Additives

read-more
read-more

API Stability Enhancers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Solubilizers

read-more
read-more

Topical

read-more
read-more

Emulsifying Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 135729-62-3 / Palonosetron API manufacturers, exporters & distributors?

Palonosetron manufacturers, exporters & distributors 1

75

PharmaCompass offers a list of Palonosetron API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Palonosetron manufacturer or Palonosetron supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Palonosetron manufacturer or Palonosetron supplier.

API | Excipient name

Palonosetron

Synonyms

135729-62-3, Palonosetron hcl, Aloxi, Onicit, Palonosetron (hydrochloride), Rs-25259-197

Cas Number

135729-62-3

Unique Ingredient Identifier (UNII)

23310D4I19

About Palonosetron

Isoquinoline and quinuclidine derivative that acts as a 5-HT3 RECEPTOR antagonist. It is used in the prevention of nausea and vomiting induced by cytotoxic chemotherapy, and for the prevention of post-operative nausea and vomiting.

Palonosetron Manufacturers

A Palonosetron manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Palonosetron, including repackagers and relabelers. The FDA regulates Palonosetron manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Palonosetron API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Palonosetron manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Palonosetron Suppliers

A Palonosetron supplier is an individual or a company that provides Palonosetron active pharmaceutical ingredient (API) or Palonosetron finished formulations upon request. The Palonosetron suppliers may include Palonosetron API manufacturers, exporters, distributors and traders.

click here to find a list of Palonosetron suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Palonosetron USDMF

A Palonosetron DMF (Drug Master File) is a document detailing the whole manufacturing process of Palonosetron active pharmaceutical ingredient (API) in detail. Different forms of Palonosetron DMFs exist exist since differing nations have different regulations, such as Palonosetron USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Palonosetron DMF submitted to regulatory agencies in the US is known as a USDMF. Palonosetron USDMF includes data on Palonosetron's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Palonosetron USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Palonosetron suppliers with USDMF on PharmaCompass.

Palonosetron JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Palonosetron Drug Master File in Japan (Palonosetron JDMF) empowers Palonosetron API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Palonosetron JDMF during the approval evaluation for pharmaceutical products. At the time of Palonosetron JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Palonosetron suppliers with JDMF on PharmaCompass.

Palonosetron KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Palonosetron Drug Master File in Korea (Palonosetron KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Palonosetron. The MFDS reviews the Palonosetron KDMF as part of the drug registration process and uses the information provided in the Palonosetron KDMF to evaluate the safety and efficacy of the drug.

After submitting a Palonosetron KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Palonosetron API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Palonosetron suppliers with KDMF on PharmaCompass.

Palonosetron WC

A Palonosetron written confirmation (Palonosetron WC) is an official document issued by a regulatory agency to a Palonosetron manufacturer, verifying that the manufacturing facility of a Palonosetron active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Palonosetron APIs or Palonosetron finished pharmaceutical products to another nation, regulatory agencies frequently require a Palonosetron WC (written confirmation) as part of the regulatory process.

click here to find a list of Palonosetron suppliers with Written Confirmation (WC) on PharmaCompass.

Palonosetron NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Palonosetron as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Palonosetron API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Palonosetron as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Palonosetron and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Palonosetron NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Palonosetron suppliers with NDC on PharmaCompass.

Palonosetron GMP

Palonosetron Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Palonosetron GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Palonosetron GMP manufacturer or Palonosetron GMP API supplier for your needs.

Palonosetron CoA

A Palonosetron CoA (Certificate of Analysis) is a formal document that attests to Palonosetron's compliance with Palonosetron specifications and serves as a tool for batch-level quality control.

Palonosetron CoA mostly includes findings from lab analyses of a specific batch. For each Palonosetron CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Palonosetron may be tested according to a variety of international standards, such as European Pharmacopoeia (Palonosetron EP), Palonosetron JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Palonosetron USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty